CD86 and COVID-19: In fact, in the severe COVID-19 patients and aging individuals, reduced numbers and altered activation of dendritic cells (DCs) were observed, with compromised CD80 and CD86 co-stimulatory molecules, which are necessary for T cell proliferation and activation [23–27].